The number of share options outstanding in a share-based payment arrangement.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2025-01-01
-Paragraph 45
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard
-URIDate 2025-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2025-01-01
-Paragraph 45
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_i&doctype=Standard
-URIDate 2025-03-27

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2025-01-01
-Paragraph 45
-Subparagraph b
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vi&doctype=Standard
-URIDate 2025-03-27

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 31
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard
-URIDate 2025-03-27

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 31
-Subparagraph b
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard
-URIDate 2025-03-27

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 31
-Subparagraph b
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard
-URIDate 2025-03-27

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 31
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_NumberOfOutstandingShareOptions
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Definition

The number of share options exercisable in a share-based payment arrangement.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2025-01-01
-Paragraph 45
-Subparagraph b
-Clause vii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vii&doctype=Standard
-URIDate 2025-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 31
-Subparagraph b
-Clause vii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vii&doctype=Standard
-URIDate 2025-03-27

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 31
-Subparagraph b
-Clause vii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vii&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]

+ References

+ Details

Name:	ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2025-01-01
-Paragraph 45
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_i&doctype=Standard
-URIDate 2025-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2025-01-01
-Paragraph 45
-Subparagraph b
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vi&doctype=Standard
-URIDate 2025-03-27

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 31
-Subparagraph b
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard
-URIDate 2025-03-27

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 31
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard
-URIDate 2025-03-27

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 31
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard
-URIDate 2025-03-27

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 31
-Subparagraph b
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]

+ References

+ Details

Name:	ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Options Exercisable [Abstract]

+ References

No definition available.

+ Details

Name:	ztek_OptionsExercisableAbstract
Namespace Prefix:	ztek_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Number Of Options Outstanding [Abstract]

+ References

No definition available.

+ Details

Name:	ztek_OptionsOutstandingAbstract
Namespace Prefix:	ztek_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ztek_RangeOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ztek_RangeTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ztek_RangeThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ztek_TrieraBiosciencesLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=ztek_RangeOfExercisePricesOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

SHARE CAPITAL (Disclosure of outstanding options to acquire common shares) (Details)	12 Months Ended
	Mar. 31, 2026 Share $ / shares	Mar. 31, 2025 Share $ / shares	Mar. 31, 2024 Share $ / shares
Options Outstanding
Number of options outstanding \| Share	5,606,667	6,123,334
Weighted Average Remaining Contractual Life (years)	2 years 6 months 18 days	2 years 3 months 29 days
Weighted average exercise price	$ 2.05	$ 2.32
Options Exercisable
Number of share options exercisable \| Share	4,102,084	4,793,750
Weighted average exercise price	$ 2.35	$ 2.54
Range of Exercise Prices One [Member]
Options Outstanding
Number of options outstanding \| Share	4,581,667	633,334
Weighted Average Remaining Contractual Life (years)	2 years 11 months 23 days	3 months 10 days
Weighted average exercise price	$ 1.55	$ 0.55
Options Exercisable
Number of share options exercisable \| Share	3,077,084	633,334
Weighted average exercise price	$ 1.71	$ 0.55
Range of Exercise Prices One [Member] \| Minimum [Member]
Options Outstanding
Weighted average exercise price	1.01	0.4
Range of Exercise Prices One [Member] \| Maximum [Member]
Options Outstanding
Weighted average exercise price	$ 4	$ 1
Range of Exercise Prices Two [Member]
Options Outstanding
Number of options outstanding \| Share	1,025,000	4,465,000
Weighted Average Remaining Contractual Life (years)	9 months 14 days	2 years 9 months
Weighted average exercise price	$ 4.27	$ 2.12
Options Exercisable
Number of share options exercisable \| Share	1,025,000	3,135,416
Weighted average exercise price	$ 4.27	$ 2.37
Range of Exercise Prices Two [Member] \| Minimum [Member]
Options Outstanding
Weighted average exercise price	4.01	1.01
Range of Exercise Prices Two [Member] \| Maximum [Member]
Options Outstanding
Weighted average exercise price	$ 5.67	$ 4
Range of Exercise Prices Three [Member]
Options Outstanding
Number of options outstanding \| Share		1,025,000
Weighted Average Remaining Contractual Life (years)		1 year 9 months 14 days
Weighted average exercise price		$ 4.27
Options Exercisable
Number of share options exercisable \| Share		1,025,000
Weighted average exercise price		$ 4.27
Range of Exercise Prices Three [Member] \| Minimum [Member]
Options Outstanding
Weighted average exercise price		4.01
Range of Exercise Prices Three [Member] \| Maximum [Member]
Options Outstanding
Weighted average exercise price		$ 5.67
Triera Biosciences Ltd [Member]
Options Outstanding
Number of options outstanding \| Share	190,000	190,000	195,000
Weighted average exercise price	$ 1	$ 1	$ 1
Triera Biosciences Ltd [Member] \| Range of Exercise Prices Four [Member]
Options Outstanding
Number of options outstanding \| Share	190,000	190,000
Weighted Average Remaining Contractual Life (years)	2 years 3 months 18 days	3 years 2 months 19 days
Weighted average exercise price	$ 1	$ 1
Options Exercisable
Number of share options exercisable \| Share	188,333	186,666
Weighted average exercise price	$ 1	$ 1
Triera Biosciences Ltd [Member] \| Range of Exercise Prices Four [Member] \| Minimum [Member]
Options Outstanding
Weighted average exercise price	0	0
Triera Biosciences Ltd [Member] \| Range of Exercise Prices Four [Member] \| Maximum [Member]
Options Outstanding
Weighted average exercise price	$ 1	$ 1